Spectrum, prevalence, and clinical correlates of <i>PPM1D</i> mutations in patients with clonal hematopoiesis and clonal cytopeniasTalha Badar, Mrinal M. Patnaik, Francyess Denis Oliva et al.|Blood Advances|2026Cited by 4
Distinct advantages for risk scoring models in patients with clonal cytopenia of undetermined significanceYazan Jabban, Aref Al‐Kali, Rong He et al.|British Journal of Haematology|2026Cited by 0